Combination Therapy With T2D Drugs to Treat NAFLD and NASH: GLP-1 Receptor Agonists Plus SGLT2 Inhibitors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Content Format:

Multimedia

Credit Type:

AAPA | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.50
Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Should We Screen for NASH?

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
NASH Core Curriculum: Risk Factors and Prognostic Indicators

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
NASH Core Curriculum: Risk Factors and Prognostic Indicators

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Frequently Asked Questions on the Management of NAFLD/NASH

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Webcast: Driving Advances in Liver Health

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Slides from Driving Advances in Liver Health—NASH: Hit the Ground Running

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How the Multifactorial Nature of NASH May Affect Treatment

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Identifying and Managing NASH in High-Risk Populations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--